84 related articles for article (PubMed ID: 8073673)
1. [Markers of genetic susceptibility to malignant neoplasms].
Polzik EV; Katsnel'son BA; Iakusheva MI; Lezhnin VL; Kazantsev VS
Vopr Onkol; 1993; 39(1-3):32-9. PubMed ID: 8073673
[TBL] [Abstract][Full Text] [Related]
2. [Genetic markers of individual predisposition to lung cancer].
Polzik EV; Katsnel'son BA; Lezhnin VL; Iakusheva MIu; Khodyrev VN
Tsitol Genet; 1992; 26(2):36-41. PubMed ID: 1615557
[TBL] [Abstract][Full Text] [Related]
3. [Some aspects of individual susceptibility to cancer and approach to its prevention].
Polzik EV; Katsnelśon BA
Med Tr Prom Ekol; 1993; (5-6):38-41. PubMed ID: 8069506
[TBL] [Abstract][Full Text] [Related]
4. [Dermatoglyphics and cancerous diseases].
Polzik EV; Katsnel'son BA; Iakusheva MIu; Lezhnin VL; Kazantsev VS
Tsitol Genet; 1994; 28(4):72-9. PubMed ID: 7801387
[TBL] [Abstract][Full Text] [Related]
5. Dermatoglyphs and gastric cancer.
Zivanović-Posilović G; Milicić J; Bozicević D
Coll Antropol; 2003 Jun; 27(1):213-9. PubMed ID: 12974149
[TBL] [Abstract][Full Text] [Related]
6. [Clinical immunogenetics of stomach cancer in Western Siberia].
Konenkov VI; Arshba GA; Korotkova II; Prokof'ev VF; Egorov DN; Vardosanidze KV
Vopr Onkol; 1997; 43(3):269-72. PubMed ID: 9245080
[TBL] [Abstract][Full Text] [Related]
7. Relationship between genetic anomalies of different levels and deviations in dermatoglyphic traits. Part 7: Dermatoglyphic peculiarities of females with cervical and endometrial carcinoma.
Bejerano M; Yakovenko K; Katznelson MB; Kobyliansky E
Z Morphol Anthropol; 2001; 83(1):75-108. PubMed ID: 11372469
[TBL] [Abstract][Full Text] [Related]
8. HLA genotype and development of gastric cancer in patients with Helicobacter pylori infection.
Hirata I; Murano M; Ishiguro T; Toshina K; Wang FY; Katsu K
Hepatogastroenterology; 2007 Jun; 54(76):990-4. PubMed ID: 17629023
[TBL] [Abstract][Full Text] [Related]
9. HLA antigens and Ia antibody in the gastric cancer patient.
Tsuji K; Ito M; Inouye H; Nose Y; Hoshino K; Shibuya K; Tajima T; Mitomi T
Prog Clin Biol Res; 1977; 16():29-37. PubMed ID: 905325
[TBL] [Abstract][Full Text] [Related]
10. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
11. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
12. Risk for smoking-related cancer among relatives of lung cancer patients.
Etzel CJ; Amos CI; Spitz MR
Cancer Res; 2003 Dec; 63(23):8531-5. PubMed ID: 14679021
[TBL] [Abstract][Full Text] [Related]
13. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population.
Quintero E; Pizarro MA; Rodrigo L; Piqué JM; Lanas A; Ponce J; Miño G; Gisbert J; Jurado A; Herrero MJ; Jiménez A; Torrado J; Ponte A; Díaz-de-Rojas F; Salido E
Helicobacter; 2005 Feb; 10(1):12-21. PubMed ID: 15691311
[TBL] [Abstract][Full Text] [Related]
14. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
15. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
16. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
18. Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancer.
Shin MC; Lee SJ; Choi JE; Cha SI; Kim CH; Lee WK; Kam S; Kang YM; Jung TH; Park JY
Jpn J Clin Oncol; 2006 Aug; 36(8):483-8. PubMed ID: 16803845
[TBL] [Abstract][Full Text] [Related]
19. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
